OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Downregulation of CAMK2N1 due to DNA Hypermethylation Mediated by DNMT1 that Promotes the Progression of Prostate Cancer
Wei Peng, Huan Feng, Linhao Pang, et al.
Journal of Oncology (2023) Vol. 2023, pp. 1-15
Open Access | Times Cited: 8
Wei Peng, Huan Feng, Linhao Pang, et al.
Journal of Oncology (2023) Vol. 2023, pp. 1-15
Open Access | Times Cited: 8
Showing 8 citing articles:
Phytochemical synergies in BK002: advanced molecular docking insights for targeted prostate cancer therapy
Moon Nyeo Park, Jinwon Choi, Md. Maharub Hossain Fahim, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Moon Nyeo Park, Jinwon Choi, Md. Maharub Hossain Fahim, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Air pollution and prostate cancer: Unraveling the connection through network toxicology and machine learning
Yuqi Li, Tao Zhou, Zhiyu Liu, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 292, pp. 117966-117966
Open Access | Times Cited: 1
Yuqi Li, Tao Zhou, Zhiyu Liu, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 292, pp. 117966-117966
Open Access | Times Cited: 1
Rescuing DNMT1 fails to fully reverse the molecular and functional repercussions of its loss in mouse embryonic stem cells
Elizabeth Elder, Anthony Lemieux, Lisa‐Marie Legault, et al.
Nucleic Acids Research (2025) Vol. 53, Iss. 4
Open Access
Elizabeth Elder, Anthony Lemieux, Lisa‐Marie Legault, et al.
Nucleic Acids Research (2025) Vol. 53, Iss. 4
Open Access
Innovative Drug Modalities for the Treatment of Advanced Prostate Cancer
Maurizio Capuozzo, Mariachiara Santorsola, Monica Ianniello, et al.
Diseases (2024) Vol. 12, Iss. 5, pp. 87-87
Open Access | Times Cited: 3
Maurizio Capuozzo, Mariachiara Santorsola, Monica Ianniello, et al.
Diseases (2024) Vol. 12, Iss. 5, pp. 87-87
Open Access | Times Cited: 3
Recent advances on gene-related DNA methylation in cancer diagnosis, prognosis, and treatment: a clinical perspective
Alessandro Lavoro, Daria Ricci, Giuseppe Gattuso, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
Alessandro Lavoro, Daria Ricci, Giuseppe Gattuso, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
Promoter Hypermethylation of the BRCA1 Gene as a Novel Biomarker for Prostate Cancer
Mohammed A Saleem, Mustafa S Mustafa
Cureus (2024)
Open Access | Times Cited: 1
Mohammed A Saleem, Mustafa S Mustafa
Cureus (2024)
Open Access | Times Cited: 1
Targeting CAMK2N1/CAMK2 inhibits invasion, migration and angiogenesis of non-small cell lung cancer by promoting autophagy and apoptosis via AKT/mTOR signaling pathway
Qiang Wang, Chao Zhang, Hai Jiang, et al.
Gene (2024) Vol. 913, pp. 148375-148375
Closed Access
Qiang Wang, Chao Zhang, Hai Jiang, et al.
Gene (2024) Vol. 913, pp. 148375-148375
Closed Access
FERMT1 contributes to the progression of prostate cancer through the p53 pathway
Xiang Sun, Lingmin Fu, Qingke Chen
Research Square (Research Square) (2024)
Open Access
Xiang Sun, Lingmin Fu, Qingke Chen
Research Square (Research Square) (2024)
Open Access
